Med-X

Exploring the promise of designed circular RNA treatments

Updated

Abstract

Circular RNAs (circRNAs) may enable long-lasting protein expression due to their resistance to degradation.

  • CircRNAs are formed through a process called back-splicing, resulting in a covalently closed circular structure.
  • These RNA molecules are less susceptible to degradation by enzymes and show reduced immune system activation.
  • Endogenous circRNAs can affect gene expression by interacting with other molecules and may enhance protein production without the need for a cap structure.
  • Dysregulated circRNAs have been linked to various diseases, including cancer and metabolic disorders.
  • Recent advancements in technology allow for the efficient creation of synthetic circRNAs with improved properties for therapeutic use.
  • Innovations in delivery methods such as lipid nanoparticles and viral vectors are expanding the potential applications of circRNAs in treating diseases.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing interestsW.T. is an editorial member of this journal. W.T. declares the following competing financial interests: W.T. receives consults (or is on scientific advisory boards) for, lectured (and received a fee), or conducts sponsored research at Harvard Medical School/Brigham and Women’s Hospital for Novo Nordisk A/S and Henlius USA Inc.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free